EPIQ Capital Group »

Abcellera Biologics shares owned by EPIQ Capital Group

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by EPIQ Capital Group from 13F filings

Historical chart of EPIQ Capital Group investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by EPIQ Capital Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by EPIQ Capital Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $493k 86k 5.71
2023-09-30 $397k 86k 4.60
2023-06-30 $557k 86k 6.46
2023-03-31 $651k 86k 7.54
2022-12-31 $874k 86k 10.13
2022-09-30 $853k 86k 9.89
2022-06-30 $1.2M 110k 10.65
2022-03-31 $889k 91k 9.75
2021-12-31 $1.3M 92k 14.30
2021-09-30 $2.9M 143k 20.04